Division and Adaptation to Host Environment of Apicomplexan Parasites Depend on Apicoplast Lipid Metabolic Plasticity and Host Organelle Remodeling.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
17 03 2020
Historique:
received: 22 03 2019
revised: 12 11 2019
accepted: 19 02 2020
entrez: 19 3 2020
pubmed: 19 3 2020
medline: 24 3 2021
Statut: ppublish

Résumé

Apicomplexan parasites are unicellular eukaryotic pathogens that must obtain and combine lipids from both host cell scavenging and de novo synthesis to maintain parasite propagation and survival within their human host. Major questions on the role and regulation of each lipid source upon fluctuating host nutritional conditions remain unanswered. Characterization of an apicoplast acyltransferase, TgATS2, shows that the apicoplast provides (lyso)phosphatidic acid, required for the recruitment of a critical dynamin (TgDrpC) during parasite cytokinesis. Disruption of TgATS2 also leads parasites to shift metabolic lipid acquisition from de novo synthesis toward host scavenging. We show that both lipid scavenging and de novo synthesis pathways in wild-type parasites exhibit major metabolic and cellular plasticity upon sensing host lipid-deprived environments through concomitant (1) upregulation of de novo fatty acid synthesis capacities in the apicoplast and (2) parasite-driven host remodeling to generate multi-membrane-bound structures from host organelles that are imported toward the parasite.

Identifiants

pubmed: 32187549
pii: S2211-1247(20)30240-0
doi: 10.1016/j.celrep.2020.02.072
pii:
doi:

Substances chimiques

Fatty Acids 0
Protozoan Proteins 0
Acyltransferases EC 2.3.-
Fatty Acid Synthases EC 2.3.1.85

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3778-3792.e9

Informations de copyright

Copyright © 2020. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Auteurs

Souad Amiar (S)

ApicoLipid Team, Institute for Advanced Biosciences, CNRS UMR5309, Université Grenoble Alpes, INSERM U1209, Grenoble, France.

Nicholas J Katris (NJ)

ApicoLipid Team, Institute for Advanced Biosciences, CNRS UMR5309, Université Grenoble Alpes, INSERM U1209, Grenoble, France.

Laurence Berry (L)

Dynamique des interactions Membranaires normales et pathologiques, UMR5235, Université Montpellier II, Montpellier, France.

Sheena Dass (S)

ApicoLipid Team, Institute for Advanced Biosciences, CNRS UMR5309, Université Grenoble Alpes, INSERM U1209, Grenoble, France.

Samuel Duley (S)

ApicoLipid Team, Institute for Advanced Biosciences, CNRS UMR5309, Université Grenoble Alpes, INSERM U1209, Grenoble, France.

Christophe-Sebastien Arnold (CS)

ApicoLipid Team, Institute for Advanced Biosciences, CNRS UMR5309, Université Grenoble Alpes, INSERM U1209, Grenoble, France.

Melanie J Shears (MJ)

McFadden Laboratory, School of Biosciences, University of Melbourne, Melbourne, VIC 3010, Australia.

Camille Brunet (C)

ApicoLipid Team, Institute for Advanced Biosciences, CNRS UMR5309, Université Grenoble Alpes, INSERM U1209, Grenoble, France.

Bastien Touquet (B)

Team Cell and Membrane Dynamics of Parasite-Host Interaction, Institute for Advanced Biosciences, INSERM 1209, CNRS UMR5309, Université Grenoble Alpes, Grenoble, France.

Geoffrey I McFadden (GI)

McFadden Laboratory, School of Biosciences, University of Melbourne, Melbourne, VIC 3010, Australia.

Yoshiki Yamaryo-Botté (Y)

ApicoLipid Team, Institute for Advanced Biosciences, CNRS UMR5309, Université Grenoble Alpes, INSERM U1209, Grenoble, France. Electronic address: yoshiki.yamaryo@gmail.com.

Cyrille Y Botté (CY)

ApicoLipid Team, Institute for Advanced Biosciences, CNRS UMR5309, Université Grenoble Alpes, INSERM U1209, Grenoble, France. Electronic address: cyrille.botte@univ-grenoble-alpes.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH